Highbridge Capital Management’s Eli Lilly LLY Stock Holding History

Highbridge Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,700	Closed	-$405K	–	705
2018 Q2	$405K	Buy	+4,700	New	+$386K	0.01%	636
2017 Q2	–	Sell	-154,100	Closed	-$13M	–	1433
2017 Q1	$13M	Buy	154,100 +4,100	+3%	+$328K	0.19%	145
2016 Q4	$11M	Buy	150,000 +70,000	+88%	+$5.21M	0.2%	139
2016 Q3	$6.42M	Buy	+80,000	New	+$6.4M	0.1%	226
2016 Q1	–	Sell	-11,400	Closed	-$960K	–	1667
2015 Q4	$960K	Sell	11,400 -34,200	-75%	-$2.84M	0.01%	767
2015 Q3	$3.82M	Buy	45,600 +5,400	+13%	+$456K	0.06%	366
2015 Q2	$3.36M	Buy	+40,200	New	+$3.06M	0.04%	386
2014 Q2	–	Sell	-18,300	Closed	-$1.08M	–	1191
2014 Q1	$1.08M	Sell	18,300 -43,800	-71%	-$2.44M	0.01%	526
2013 Q4	$3.17M	Buy	62,100 +50,300	+426%	+$2.52M	0.04%	328
2013 Q3	$593K	Buy	+11,800	New	+$618K	0.01%	831

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Highbridge Capital Management's LLY Position: Q4 2018 in Review

Highbridge Capital Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 26,779 shares — an estimated $2.87M sold.

Highbridge Capital Management first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $46.4M in Q4 2013. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Highbridge Capital Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 26,779 Eli Lilly shares in Q4 2018, an estimated $2.87M.
Highbridge Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
Highbridge Capital Management's Eli Lilly position peaked at $46.4M in Q4 2013.
1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.